Catalyst Wire Dossier Catalyst Wire Dossier

Surufatinib

Surufatinib
Drug timelines are a Plus or Pro feature.

73 regulatory and trial events tracked for Surufatinib, covering 2019-02-27 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study

See pricing